We provide you with 20 years of free, institutional-grade data for ADPT stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of ADPT. Explore the full financial landscape of ADPT stock.
Total insider purchase within 3 month on this page: $0
Total insider selling within 3 month on this page: -$21,747,554
| Name | Action | Shares | Avg Price | Amount | Reported Date |
|---|---|---|---|---|---|
| ROBINS HARLAN S | Sale | -386,240 | $21.74 | $8,396,858 | 2026-07-07 |
| LO FRANCIS | Sale | -95,842 | $22.18 | $2,125,776 | 2026-07-06 |
| LO FRANCIS | Derivatives Exercise | 75,621 | 2026-07-06 | ||
| BOBULSKY SUSAN | Sale | -487 | $22 | $10,714 | 2026-07-06 |
| BENZENO SHARON | Sale | -165,802 | $21 | $3,481,842 | 2026-06-30 |
| BENZENO SHARON | Derivatives Exercise | 114,329 | 2026-06-30 | ||
| BOBULSKY SUSAN | Sale | -5,000 | $20.5 | $102,500 | 2026-06-29 |
| GRIFFIN MICHELLE RENEE | Sale | -52,084 | $20.18 | $1,051,055 | 2026-06-29 |
| GRIFFIN MICHELLE RENEE | Derivatives Exercise | 52,084 | 2026-06-29 | ||
| ROBINS HARLAN S | Sale | -106,160 | $17.37 | $1,843,999 | 2026-06-17 |
| BOBULSKY SUSAN | Sale | -5,000 | $19 | $95,000 | 2026-06-15 |
| LO FRANCIS | Sale | -39,741 | $17.49 | $695,070 | 2026-06-08 |
| LO FRANCIS | Derivatives Exercise | 19,521 | 2026-06-08 | ||
| BOBULSKY SUSAN | Sale | -11,000 | $18 | $198,000 | 2026-06-08 |
| PISKEL KYLE | Sale | -3,115 | $13.04 | $40,620 | 2026-05-20 |
| RUBINSTEIN JULIE | Sale | -19,037 | $14.23 | $270,897 | 2026-04-29 |
| RUBINSTEIN JULIE | Derivatives Exercise | 14,707 | 2026-04-29 | ||
| RUBINSTEIN JULIE | Sale | -57,180 | $14.13 | $807,953 | 2026-04-24 |
| RUBINSTEIN JULIE | Derivatives Exercise | 44,166 | 2026-04-24 | ||
| RUBINSTEIN JULIE | Sale | -69,061 | $14.57 | $1,006,219 | 2026-04-21 |
| RUBINSTEIN JULIE | Derivatives Exercise | 56,047 | 2026-04-21 | ||
| RUBINSTEIN JULIE | Sale | -57,180 | $14.56 | $832,541 | 2026-04-16 |
| RUBINSTEIN JULIE | Derivatives Exercise | 44,166 | 2026-04-16 | ||
| RUBINSTEIN JULIE | Sale | -57,180 | $13.79 | $788,512 | 2026-04-13 |
| RUBINSTEIN JULIE | Derivatives Exercise | 44,166 | 2026-04-13 | ||
| LO FRANCIS | Sale | -22,564 | $15.07 | $340,039 | 2026-04-10 |
| LO FRANCIS | Derivatives Exercise | 2,344 | 2026-04-10 | ||
| ROBINS HARLAN S | Sale | -10,000 | $14.85 | $148,500 | 2026-04-10 |
| ROBINS CHAD M | Sale | -120,595 | $14.41 | $1,737,774 | 2026-04-08 |
| RUBINSTEIN JULIE | Sale | -69,061 | $14.33 | $989,644 | 2026-04-08 |
| RUBINSTEIN JULIE | Derivatives Exercise | 56,047 | 2026-04-08 | ||
| RUBINSTEIN JULIE | Sale | -38,120 | $14.45 | $550,834 | 2026-04-02 |
| RUBINSTEIN JULIE | Derivatives Exercise | 29,444 | 2026-04-02 | ||
| RUBINSTEIN JULIE | Sale | -57,180 | $12.49 | $714,178 | 2026-03-31 |
| RUBINSTEIN JULIE | Derivatives Exercise | 44,166 | 2026-03-31 | ||
| RUBINSTEIN JULIE | Sale | -57,180 | $13.7 | $783,366 | 2026-03-26 |
| RUBINSTEIN JULIE | Derivatives Exercise | 44,166 | 2026-03-26 | ||
| RUBINSTEIN JULIE | Sale | -57,180 | $13.18 | $753,632 | 2026-03-23 |
| RUBINSTEIN JULIE | Derivatives Exercise | 44,166 | 2026-03-23 | ||
| RUBINSTEIN JULIE | Sale | -57,180 | $13.41 | $766,784 | 2026-03-18 |
| RUBINSTEIN JULIE | Derivatives Exercise | 44,166 | 2026-03-18 | ||
| LO FRANCIS | Sale | -3,125 | $16.08 | $50,250 | 2026-01-06 |
| LO FRANCIS | Derivatives Exercise | 3,125 | 2026-01-06 | ||
| LO FRANCIS | Sale | -4,394 | $17.5 | $76,895 | 2025-12-29 |
| LO FRANCIS | Derivatives Exercise | 4,394 | 2025-12-29 | ||
| LO FRANCIS | Sale | -113,890 | $15.57 | $1,773,267 | 2025-12-17 |
| LO FRANCIS | Derivatives Exercise | 97,022 | 2025-12-17 | ||
| HERSHBERG ROBERT | Sale | -22,968 | $16 | $367,488 | 2025-12-12 |
| BENZENO SHARON | Sale | -12,604 | $16.85 | $212,377 | 2025-12-08 |
| BENZENO SHARON | Derivatives Exercise | 12,604 | 2025-12-08 | ||
| ROBINS HARLAN S | Sale | -37,212 | $18.61 | $692,515 | 2025-12-05 |
| PISKEL KYLE | Sale | -162,820 | $19.5 | $3,174,990 | 2025-12-02 |
| PISKEL KYLE | Derivatives Exercise | 110,114 | 2025-12-02 | ||
| ROBINS CHAD M | Sale | -160,734 | $19.68 | $3,163,245 | 2025-12-01 |
| BENZENO SHARON | Sale | -606,402 | $16.54 | $10,029,889 | 2025-11-24 |
| BENZENO SHARON | Derivatives Exercise | 510,470 | 2025-11-24 | ||
| PISKEL KYLE | Sale | -238 | $14.05 | $3,344 | 2025-11-18 |
The information provided in this report about ADPT stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Adaptive Biotechnologies Corporation(NASDAQ:ADPT) 
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ research service and kit that is used to answer translational research questions, as well as to discover new progno...
Website: http://www.adaptivebiotech.com
Founded: 2009
IPO Price: $20 (Jun 27, 2019)
Full Time Employees: 453
CEO: Chad Robins
Sector: Healthcare
Industry: Biotechnology